• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

202.42 +2.94 (+1.47%)
Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
December 11, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Evercore Healthcare Conference
December 01, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
November 24, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
November 17, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Provides Update on Strategic Review
November 05, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Third-Quarter 2025 Results
November 05, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
October 27, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
October 22, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
October 20, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
October 15, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
October 14, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
October 08, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Chief Financial Officer Transition
September 16, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
September 11, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
September 08, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences
September 03, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
August 26, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Second-Quarter 2025 Results
August 06, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership
July 31, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Joins Elly’s Team to Drive Rare Disease Gene Therapy Development
July 22, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
July 15, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
June 16, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at William Blair and Jefferies Conferences
June 02, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 28, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Bank of America Health Care Conference
May 13, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces First-Quarter 2025 Results
May 07, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
May 07, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
April 29, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
April 22, 2025
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap